PolarityTE

PolarityTE EBITDA

Delisted

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PolarityTE (PTE) as of Nov 20, 2026 is -24.37 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -29.73 M USD — a change of -18.02% (higher).

EBITDA

-24.37 MUSD

YoY

-18.02%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PolarityTE is 2022 -24.37 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PolarityTE was 2021 -29.73 M USD. It decreases by -18.02% higher compared to the previous year.

The PolarityTE EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2015
-4.10 M USD
Jan 1, 2016
-130.60 M USD
Jan 1, 2017
-69.40 M USD
Jan 1, 2018
-18.20 M USD
Jan 1, 2019
-90.40 M USD
Jan 1, 2020
-39.03 M USD
Jan 1, 2021
-29.73 M USD
Jan 1, 2022
-24.37 M USD
The PolarityTE EBITDA history
YEAREBITDAYoY
-24.37 MUSD-18.02%
-29.73 MUSD-23.84%
-39.03 MUSD-56.82%
-90.40 MUSD+396.70%
-18.20 MUSD-73.78%
-69.40 MUSD-46.86%
-130.60 MUSD+3,085.37%
-4.10 MUSD+36.67%
-3.00 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PolarityTE Stock analysis

What does PolarityTE do? PolarityTE Inc is an innovative biotechnology company specializing in tissue and organ regeneration. The company's developed technologies allow for the creation of functional human tissue from a patient's own stem cells. The history of PolarityTE Inc began in Utah, USA, in 2016 when the company was founded by Dr. Denver Lough, a plastic surgeon. Dr. Lough and his team had a vision to build a new type of medical company that not only addresses the symptoms of diseases but also their root causes. PolarityTE Inc operates on a unique business model based on holistic and personalized medicine. The company utilizes state-of-the-art technologies to offer personalized therapies for patients suffering from a variety of conditions, including burns, wounds, scleroderma, and other tissue-damaging diseases. The different divisions of PolarityTE Inc include research and development of innovative drugs and technologies, clinical trials, product launches, and collaboration with experts from various fields to continuously improve the offering of products and services. The company offers a range of products made from regenerative tissue. The portfolio of PolarityTE Inc includes SkinTE, OsteoTE, and CartTe, each tailored to the specific needs of patients. SkinTE is a groundbreaking therapy for regenerating skin tissue, designed to accelerate the repair of damaged skin. The treatment aims to reduce the need for skin grafts and expedite the healing process of wounds and burns. OsteoTE is an innovative method for regenerating bone tissue, with the potential to revolutionize the treatment of bone fractures. The treatment utilizes the regenerative abilities of cells to promote the growth of healthy bone and expedite the healing of fractures. CartTe is a therapy for regenerating cartilage tissue, aiming to help people with joint pain and discomfort. The treatment harnesses the body's ability to repair damaged tissue, stimulating the growth of novel cartilage cells and improving joint function. Overall, PolarityTE Inc has the potential to revolutionize the treatment of wounds and diseases. The company focuses on personalized medicine based on individual patient needs and promotes the development of therapies targeting the root causes of diseases. PolarityTE is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PolarityTE stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PolarityTE is -24.37 M USD in 2022.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PolarityTE changed from -29.73 M USD to -24.37 M USD, representing a -18.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) PolarityTE since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s PolarityTE historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — PolarityTE

All Key Metrics — PolarityTE